share_log

ハートシードなどが引き続きランクイン、他家iPS細胞由来心筋球治験で高用量群1例目レビュー完了

Heart seed etc. continues to rank in, with the first case of high-dose group review completion in other households' iPS cell-derived myocardial sphere clinical trials.

Fisco Japan ·  Oct 2 09:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment